123 related articles for article (PubMed ID: 11395505)
1. Effects of diabetes insipidus mutations on neurophysin folding and function.
Eubanks S; Nguyen TL; Deeb R; Villafania A; Alfadhli A; Breslow E
J Biol Chem; 2001 Aug; 276(32):29671-80. PubMed ID: 11395505
[TBL] [Abstract][Full Text] [Related]
2. Properties of human vasopressin precursor constructs: inefficient monomer folding in the absence of copeptin as a potential contributor to diabetes insipidus.
Barat C; Simpson L; Breslow E
Biochemistry; 2004 Jun; 43(25):8191-203. PubMed ID: 15209516
[TBL] [Abstract][Full Text] [Related]
3. Modulation of dimerization, binding, stability, and folding by mutation of the neurophysin subunit interface.
Eubanks S; Nguyen TL; Peyton D; Breslow E
Biochemistry; 2000 Jul; 39(27):8085-94. PubMed ID: 10891091
[TBL] [Abstract][Full Text] [Related]
4. Expression, folding, and thermodynamic properties of the bovine oxytocin-neurophysin precursor: relationships to the intermolecular oxytocin-neurophysin complex.
Eubanks S; Lu M; Peyton D; Breslow E
Biochemistry; 1999 Oct; 38(41):13530-41. PubMed ID: 10521260
[TBL] [Abstract][Full Text] [Related]
5. Contributions of the interdomain loop, amino terminus, and subunit interface to the ligand-facilitated dimerization of neurophysin: crystal structures and mutation studies of bovine neurophysin-I.
Li X; Lee H; Wu J; Breslow E
Protein Sci; 2007 Jan; 16(1):52-68. PubMed ID: 17192588
[TBL] [Abstract][Full Text] [Related]
6. Thermodynamic role of the pro region of the neurophysin precursor in neurophysin folding: evidence from the effects of ligand peptides on folding.
Deeb R; Breslow E
Biochemistry; 1996 Jan; 35(3):864-73. PubMed ID: 8547267
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation (R97C) in the neurophysin moiety of prepro-vasopressin-neurophysin II associated with autosomal-dominant neurohypophyseal diabetes insipidus.
Rutishauser J; Kopp P; Gaskill MB; Kotlar TJ; Robertson GL
Mol Genet Metab; 1999 May; 67(1):89-92. PubMed ID: 10329029
[TBL] [Abstract][Full Text] [Related]
8. Sequence redesign and the assembly mechanism of the oxytocin/bovine neurophysin I biosynthetic precursor.
Ando S; McPhie P; Chaiken IM
J Biol Chem; 1987 Sep; 262(27):12962-9. PubMed ID: 3654597
[TBL] [Abstract][Full Text] [Related]
9. Autosomal dominant neurohypophyseal diabetes insipidus in a Swiss family, caused by a novel mutation (C59Delta/A60W) in the neurophysin moiety of prepro-vasopressin-neurophysin II (AVP-NP II).
Flück CE; Deladoëy J; Nayak S; Zeller O; Kopp P; Mullis PE
Eur J Endocrinol; 2001 Oct; 145(4):439-44. PubMed ID: 11581002
[TBL] [Abstract][Full Text] [Related]
10. The behavior of the active site salt bridge of bovine neurophysins as monitored by 15N NMR spectroscopy and chemical substitution. Relationship to biochemical properties.
Zheng C; Cahill S; Breslow E
Biochemistry; 1996 Sep; 35(36):11763-72. PubMed ID: 8794757
[TBL] [Abstract][Full Text] [Related]
11. Amino acid sequence and properties of vasopressin-associated elephant neurophysin.
Huang HB; Wellner D; Naudé R; Oelofsen W; Oosthuizen MM; Breslow E
Int J Pept Protein Res; 1994 Sep; 44(3):270-7. PubMed ID: 7822104
[TBL] [Abstract][Full Text] [Related]
12. Heterologous expression of human vasopressin-neurophysin precursors in a pituitary cell line: defective transport of a mutant protein from patients with familial diabetes insipidus.
Olias G; Richter D; Schmale H
DNA Cell Biol; 1996 Nov; 15(11):929-35. PubMed ID: 8945633
[TBL] [Abstract][Full Text] [Related]
13. Structural modeling of the pro-ocytocin-neurophysin precursor.
Velikson B; Cohen P; Rholam M; Rose JP; Wang BC; Smith JC
Protein Eng; 1998 Oct; 11(10):909-16. PubMed ID: 9862210
[TBL] [Abstract][Full Text] [Related]
14. NMR analysis of the monomeric form of a mutant unliganded bovine neurophysin: comparison with the crystal structure of a neurophysin dimer.
Nguyen TL; Breslow E
Biochemistry; 2002 May; 41(18):5920-30. PubMed ID: 11980496
[TBL] [Abstract][Full Text] [Related]
15. A novel mutation in the coding region for neurophysin-II is associated with autosomal dominant neurohypophyseal diabetes insipidus.
Rauch F; Lenzner C; Nürnberg P; Frömmel C; Vetter U
Clin Endocrinol (Oxf); 1996 Jan; 44(1):45-51. PubMed ID: 8706292
[TBL] [Abstract][Full Text] [Related]
16. A de novo mutation in the coding sequence for neurophysin-II (Pro24-->Leu) is associated with onset and transmission of autosomal dominant neurohypophyseal diabetes insipidus.
Repaske DR; Browning JE
J Clin Endocrinol Metab; 1994 Aug; 79(2):421-7. PubMed ID: 8045958
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus caused by a mutation encoding Ala-1-->Val in the signal peptide of the arginine vasopressin/neurophysin II/copeptin precursor.
Repaske DR; Medlej R; Gültekin EK; Krishnamani MR; Halaby G; Findling JW; Phillips JA
J Clin Endocrinol Metab; 1997 Jan; 82(1):51-6. PubMed ID: 8989232
[TBL] [Abstract][Full Text] [Related]
18. NG peptides: a novel family of neurophysin-associated neuropeptides.
Elphick MR
Gene; 2010 Jun; 458(1-2):20-6. PubMed ID: 20303398
[TBL] [Abstract][Full Text] [Related]
19. Slowly interchanging conformers of bovine neurophysin-I in the unliganded dimeric state.
Breslow E; Mishra PK; Huang HB; Bothner-by A
Biochemistry; 1992 Nov; 31(46):11397-404. PubMed ID: 1445877
[TBL] [Abstract][Full Text] [Related]
20. Molecular biology of diabetes insipidus.
Fujiwara TM; Morgan K; Bichet DG
Annu Rev Med; 1995; 46():331-43. PubMed ID: 7541187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
